Schedule 13G ownership disclosure

Bellerophon Therapeutics, Inc.

Security class unavailable · CUSIP: 078771102

Event date: 2020-03-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
302,083
Percent of class
5.1300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000083
Form type
SC 13G
Filer
Bellerophon Therapeutics, Inc.
CIK
CIK 1600132
Filed
Mar 30, 2020
Reporting period
Mar 30, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub